MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

MGI Tech Singapore Pte, Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore (“NCCS”) to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI’s core DNBSEQ™ technology.

Interview With Psychedelic Athlete Ian McCall | Psychedelic Invest

Ian Mccall is a former MMA world champion and UFC fighter who, since his retirement, has shifted his focus to helping athletes heal through psychedelics.

September 11, 2023

SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven – Biotech Investments

EQS-News: SYNLAB AG / Key word(s): Agreement/Strategic Company Decision SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven 29.09.2023

September 30, 2023

Cosmochemistry techniques shed light on potential new Alzheimer’s disease biomarker

The study identifies lower potassium isotope ratios in Alzheimer’s patients, suggesting δ41K as a viable biomarker for early detection of the disease.

September 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.